NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
CC E-029-2011-1-EP-01 Therapeutic apparatus for heating a subject EP ORD 11154471.4 Abandoned
CC E-029-2011-2-EP-06 Therapeutic Apparatus And Method For Heating A Subject EP DIV 20110154471 Abandoned
NCATS E-069-2014-0-US-01 Novel inhibitors of protein kinase signaling that are neuroprotective and have potential applicability for the treatment of glaucoma, optic nerve disease, and other forms of neurodegeneration US 61/443,035 Abandoned
NIAID E-260-2010-0-US-01 Immunotoxins Against Glycoprotein H Of Kaposi's Sarcoma-associated Herpesvirus US 61/442,902 Abandoned
NEI E-169-2008-0-CA-04 Methods for Using Interferon Gamma to Absorb Fluid From the Subretinal Space CA National Stage 2734185 Issued
NINR E-280-2010-0-US-01 Biomarkers For Cancer-Related Fatigue And Use Thereof US 61/442,605 Abandoned
NCI E-159-2010-0-PCT-02 MULTIMERIC PROTEINS COMPRISING IMMUNOGLOBULIN CONSTANT DOMAINS PCT PCT PCT/US2011/024552 Expired
NCI E-159-2010-0-US-06 Multimeric Proteins From Isolated Engineered Antibody Domains US National Stage 13/578,538 Abandoned
NCI E-159-2010-0-EP-05 Multimeric Proteins From Isolated Engineered Antibody Domains EP National Stage 11742876.3 Abandoned
NIEHS E-180-2011-3-US-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A GENETIC PREDISPOSITION TO PARKINSON DISEASE US 61/441,912 Abandoned
NCI E-159-2010-0-CA-04 Multimeric Proteins From Isolated Engineered Antibody Domains CA National Stage 2789328 Abandoned
NCI E-159-2010-0-AU-03 Multimeric Proteins From Isolated Engineered Antibody Domains AU National Stage 2011215684 Abandoned
NCI E-104-2006-0-US-18 Immunogenic Peptides And Methods Of Use US CON 13/025,094 9175057 Issued PDF
NCI E-124-2004-2-US-07 METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR US DIV 13/024,845 Abandoned
NCI E-082-2010-0-PCT-02 Inhibition Of Antibody Responses To Foreign Proteins PCT PCT PCT/US2011/024382 Expired
NHLBI E-011-2010-0-EP-03 Compositions And Methods For Preventing or Treating A Human Parvovirus Infection EP National Stage 11730103.6 Abandoned
NHLBI E-011-2010-0-PCT-02 Compositions And Methods For Preventing or Treating A Human Parvovirus Infection PCT PCT PCT/US2011/024199 Expired
NHLBI E-254-2011-1-US-01 Critical Cysteine Oxidation Is Reduced During Ischemia-Reperfusion
Injury Via S-nitrosothiol Formation And Identification Of The Myocardial S-nitrosothiol Proteome 		US 61/440,638 Abandoned
NICHD E-069-2000-2-US-13 Method Of Making And Using 7alpha, 11Beta-Dimethyl-17Beta-Hydroxyestr-4-En-3-One 17-Undecanoate US CON 13/022,391 10351587 Abandoned PDF
NCI E-106-2003-0-US-12 Griffithsin, Glycosylation-Resistant Griffithsin, And Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods Of Production And Methods Of Use US DIV 13/022,289 8394764 Expired PDF
NHGRI E-090-2010-0-NZ-04 METHODS OF DIAGNOSIS AND PROGNOSIS OF SKIN CANCER NZ National Stage 590993 Abandoned
NIA E-101-2010-0-PCT-02 Regulatory B Cells (tBregs) And Their Use PCT PCT PCT/US2011/023789 Expired
NCATS E-162-2008-0-US-07 Oxadiazole 2-oxides As AntiSchistosomal Agents US National Stage 13/057,667 Abandoned
NIDA E-030-2011-0-US-01 TRPA1 Gene Haplotype Associated With Menthol Preference In Two Samples Of European American Smokers US 61/439,419 Abandoned
NHLBI E-250-2010-0-US-01 Lightguides To Simplify Total Emission Detection For Multiphoton Microscopy US 61/439,616 Abandoned
NIAID E-088-2011-0-US-01 HIV Neutralizing Antibodies Having Mutations In Constant Domain(FC) US 61/439,678 Abandoned
NCI E-153-2008-0-US-06 Radioprotectants Targeting Thrombospondin-1 And CD47 US National Stage 13/057,447 8951527 Issued PDF
NCATS E-069-2011-0-US-01 Use Of Auranofin For The Treatment Of Chronic Lymphocytic Leukemia (CLL) US 61/439,186 Abandoned
CC E-285-2010-0-US-01 Superparamagnetic Nanocomplexes, Articles, And Methods Of Use Thereof US 61/439,106 Abandoned
NIAID E-032-2011-0-US-01 Multivalent Vaccines For Rabies Virus And FiloViruses US 61/439,046 Abandoned
NIAMS E-064-2011-0-US-01 Generation And Use Fab, SCFV, And Related Binding Molecules Specific For HIV-1 Rev US 61/439,307 Abandoned
NCI E-057-2012-0-US-01 HIV INTEGRASE INHIBITORS US 61/438,887 Abandoned
NHGRI E-013-2011-0-US-01 TRRAP AND GRIN2A MUTATIONS AND USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF MELANOMA US 61/462,471 Abandoned
NCI E-196-2000-0-US-05 Defensin-Antigen Fusion Proteins US CON 13/019,160 8084250 Abandoned PDF
NIAID E-084-2010-0-PCT-02 Vaccine And Methods of Use Against Strongyloides Stercoralis Infection PCT PCT PCT/US2011/023320 Expired
NIAID E-084-2010-0-EP-04 Vaccine And Methods of Use Against Strongyloides Stercoralis Infection EP National Stage 11702568.4 Abandoned
NICHD E-006-2011-0-US-01 Pertussis Vaccine US 61/438,190 Abandoned
NIAID E-057-2011-0-US-01 Virus-Like Particles (VLPs) And Methods of Use US 61/438,236 Abandoned
NIDDK E-285-2008-0-GB-10 A3 Adenosine Receptor Antagonists and Partial Agonists GB EP 09791060.8 Abandoned
NIDDK E-285-2008-0-FR-09 A3 Adenosine Receptor Antagonists and Partial Agonists FR EP 09791060.8 Abandoned
NIDDK E-285-2008-0-DE-08 A3 Adenosine Receptor Antagonists and Partial Agonists DE EP 09791060.8 Abandoned
NCI E-332-2007-0-US-08 Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-Met Signaling US National Stage 12/935,646 8569360 Abandoned PDF
NIAID E-317-2003-0-AU-08 Accelerated Vaccination AU DIV 2011200335 Expired
NCATS E-308-2009-0-PCT-02 Caspase Inhibitors PCT PCT PCT/US2011/022744 Expired
NIMH E-157-2006-1-US-06 Methods To Identify Patients At Risk Of Developing Adverse Events During Treatment With Antidepressant Medication US CON 13/015,068 Abandoned
NCI E-153-2008-0-CA-04 Radioprotectants Targeting Thrombospondin-1 And CD47 CA National Stage 2732102 Issued
NCI E-030-2004-0-US-08 Schweinfurthin Analogs US CON 13/014,479 Abandoned
NCI E-332-2007-0-US-07 Compositions And Methods For Inhibition Of Hepatocyte Growth Factor Receptor C-Met Signaling US National Stage 12/935,643 8754081 Abandoned PDF
NIA E-008-2011-0-US-01 ZSCAN4 As A Marker For Pancreatic Stem Cells And Progenitor Cells And Uses Thereof US 61/436,068 Abandoned
NEI E-075-2011-0-US-01 Methods of Diagnosing and Treating Age-Related Macular Degeneration US 61/435,989 Abandoned